Vasopressin
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Vasopressin and local guidelines before prescribing.
Vasopressin analogue
Mechanism
V1 and V2 receptor agonist.
Uses
Vasodilatory shock, variceal bleeding (terlipressin analogues preferred), diabetes insipidus.
Dosing
- Tolvaptan (a vasopressin V2 receptor antagonist, specialist). Start in hospital at a low dose (7.5–15 mg), with frequent sodium checks because of the risk of overcorrection. Avoid in liver disease (hepatotoxicity).
Endocrinology: Sodium and Water disorders - Add vasopressin ; start hydrocortisone (200 mg a day).
Critical care: Admission and organ support
Side effects
Hypertension, ischaemia, hyponatraemia, bradycardia.
Interactions
Catecholamines potentiate.
Contraindications and cautions
Coronary disease caution
Monitoring
BP, sodium
Pregnancy and breastfeeding
Use if essential
Renal and hepatic impairment
Caution in renal impairment
Overdose and reversal
Supportive
Special advice
Used with noradrenaline in refractory shock.
More from the textbook: uses, cautions and other points
- Vasopressin (ADH) : Promotes renal water retention; Can contribute to dilutional hyponatraemia; Severe hyponatraemia is associated with advanced disease and adverse prognosis.
Cardiology: Heart Failure - Avoid adrenaline and other catecholamines where possible , because they can trigger further hormone release. Use vasopressin or phenylephrine if pressors are needed, with anaesthetic advice.
Endocrinology: Emergencies - ADH (vasopressin) - from the posterior pituitary; water retention and vasoconstriction.
Cardiology: Anatomy Physiology and Pharmacology - Vasopressin | V1 receptors - vasoconstriction (not via adrenergic receptors) | Added in septic shock needing high noradrenaline
Cardiology: Anatomy Physiology and Pharmacology - Hyponatraemia : Often results from increased vasopressin-mediated water retention. May occur alongside marked fluid overload. Can also result from diuretics or other causes of sodium loss. Associated with more advanced heart failure and worse outcomes. Treatment depends on volume status, symptoms, severity and chronicity.
Cardiology: Heart Failure - Posterior pituitary (neurohypophysis) - an extension of the brain; stores and releases ADH (vasopressin) and oxytocin , made in the supraoptic and paraventricular nuclei of the hypothalamus.
Endocrine: Anatomy Physiology and Pharmacology - ADH (vasopressin) - released when plasma osmolality rises (osmoreceptors in the hypothalamus, very sensitive - a 1–2% rise) or when blood volume or pressure falls (a stronger stimulus that overrides osmolality).
Endocrine: Anatomy Physiology and Pharmacology - V1 receptors on blood vessels → vasoconstriction (vasopressin and terlipressin in shock and variceal bleeding).
Endocrine: Anatomy Physiology and Pharmacology
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Cardiology: Heart Failure (2 mentions)
- Endocrine: Anatomy Physiology and Pharmacology (3 mentions)
- Endocrinology: Emergencies (1 mention)
- Endocrinology: Sodium and Water disorders (3 mentions)
- Endocrinology: Pituitary Disease (13 mentions)
- Acute Medicine: Shock, sepsis and critical illness (2 mentions)
- Clinical Genetics: Single-gene, repeat-expansion and mitochondrial disorders (1 mention)
- Critical care: Admission and organ support (5 mentions)
- Critical care: common problems, ethics and recovery (1 mention)
- Integrated cardiology chapter (2 mentions)
- Physiology: Cells, tissues, homeostasis, fluids and acid–base balance (1 mention)
- 0268-endocrine-glands-and-their-surgical-relationships (3 mentions)
- 0284-renal-physiology-electrolytes-water-balance-and-acid-base-contr (2 mentions)